Home › Funds › Vise Technologies, Inc. › JNJ

Vise Technologies, Inc. position in JNJ

JOHNSON JOHNSON · Health Care

Vise Technologies, Inc. reported holding 275,901 shares of JNJ (JOHNSON JOHNSON) in its Q3 2026 13F filing — a position valued at US$73.0M, representing 0.62% of its reported portfolio and ranking #31 among its reported holdings. Vise Technologies, Inc. has disclosed JNJ holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)275.90K sh
Reported value held$73.04M
Portfolio Weight0.62%
First reportedQ3 2023
Last changeAdd
Updated2026-10-29

Last updated: 2026-10-29 · Source: SEC EDGAR Form 13F-HR

How Vise Technologies, Inc.'s JNJ position evolved

Vise Technologies, Inc. first disclosed a stake in JNJ in Q3 2023 at 21,323 shares (US$3.3M). The position peaked in Q3 2026 at 275,901 shares, worth US$73.0M. Across 11 filings, Vise Technologies, Inc. increased the stake 8 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 275,901 shares valued at US$73.0M — an increase of 64,038 shares quarter over quarter.. Notable position changes include a 130% increase in Q2 2025 (shares rose 22% over the following quarter), a 77% increase in Q4 2025 (shares rose 18% over the following quarter), a 110% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 21.32K $3.32M New
Q4 2023 21.87K $3.43M Add
Q1 2024 24.47K $3.87M Add
Q3 2024 30.73K $4.98M Add
Q4 2024 33.21K $4.80M Add
Q2 2025 76.50K $11.68M Add
Q3 2025 57.05K $10.58M Reduce
Q4 2025 101.12K $20.93M Add
Q1 2026 101.12K $20.93M Hold
Q2 2026 211.86K $53.81M Add
Q3 2026 275.90K $73.04M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Vise Technologies, Inc. held JNJ?

Vise Technologies, Inc. has disclosed JNJ holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

What is Vise Technologies, Inc.'s current position in JNJ?

As of Q3 2026, Vise Technologies, Inc. holds 275.90K shares of JNJ (JOHNSON JOHNSON), valued at $73.04M, representing 0.62% of its reported portfolio and ranking #31.

Has Vise Technologies, Inc. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Vise Technologies, Inc. increased its position in JNJ. The position peaked in Q3 2026 at 275.90K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.